Skip to main content

Table 2 Central Nervous System (CNS) structural abnormalities in our cohort of patients

From: CNS involvement in OFD1 syndrome: a clinical, molecular, and neuroimaging study

CNS structural abnormalities: type

MRI/p.m.*

eco/CT

Tot. N° (%) a

Tot. N° (%) b

Agenesis/hypoplasia of the Corpus Callosum (ACC)

34/42 (80.95)

11/29 (37.93)

45/71 (63.38)

45/117(38.46)

Intracerebral arachnoid cysts

19/42 (45.24)

6/29 (20.69)

25/71 (35.21)

25/117(21.36)

Malformations of cortical development (MCDs)

22/42 (52.38)

1/29 (3.45)

23/71 (32.39)

23/117(19.65)

Cerebellar developmental anomalies (CDAs)

18/42 (42.86)

2/29 (6.9)

20/71 (28.17)

20/117(17.09)

- Dandy-Walker Malformation (DWM)

5/42 (11.90)

0/29 (0)

5/71 (7.04)

5/117(4.27)

Cerebral atrophy/hypoplasia

5/42 (11.90)

4/29 (13.79)

9/71 (12.68)

9/117(7.69)

Hydrocephalus/ventriculomegaly

6/42 (14.29)

2/29 (6.9)

8/71 (11.27)

8/117(6.83)

Porencephaly

1/42 (2.38)

2/29 (6.9)

3/71 (4.22)

3/117(2.56)

Brain stem anomalies

2/42 (4.76)

0/29 (0)

2/71 (2.82)

2/117(1.7)

Hypothalamic hamartoma

1/42 (2.38)

0/29 (0)

1/71 (1.41)

1/117(0.85)

Total

42/42 (100)

21/29 (72.41)

63/71 (88.73)

63/117(53.84)

  1. *p.m. : post-mortem evaluation.
  2. apercentages calculated on the total number of cases displaying CNS involvement.
  3. bpercentages calculated on the entire cohort of cases.